Why shoppers are paying more for a fake Amazon discount

May 9, 2023

2 min

By Halle Burton


According to new research by Jinhong Xie, a Warrington College of Business professor at the University of Florida, more than a quarter of Amazon vacuum cleaners sold have increased their prices while pretending to offer discounts.


Xie’s pricing phenomenon research is joined with Sungsik Park at the University of South Carolina and Man Xie at Arizona State University, publishing their analysis in the Marketing Science journal.


A product’s price increase is paired with a previously unadvertised listing price, which encourages Amazon shoppers to receive a deceitful false discount.


This faux discount drove higher sales despite the price increase, and shoppers end up paying 23% more on average.


“When you see this list-price comparison, you naturally assume you are getting a discount. It’s not just that you didn’t get a discount. You actually paid a higher price than before the seller displayed the discount claim,” said Xie.


Regulations currently prohibit deceptive pricing by requiring truthful price comparisons from the sellers, but a list price can still be misleading under these circumstances.


Shoppers are misled by the timing of price comparisons where retailers advertise a price discount that actually only gives the impression of a deal.


“Current regulations are all about the value of the list price, and they don’t say anything about misleading consumers by manipulating the timing of the list price’s introduction,” Xie said.


Xie and her colleagues followed more than 1,700 vacuums on Amazon from 2016 to 2017 gathering observational data on their prices.


“We found that by increasing the price by 23% on average, the seller achieves a 15% advantage in their sales rank among all products in the home and kitchen category,” Xie said.


Xie encourages consumers to be aware, not make assumptions about discount claims and utilize multiple websites to compare prices.


“We think that consumer organizations and regulators should evaluate this new marketing practice to determine whether and how to manage it.”

You might also like...

Check out some other posts from University of Florida

3 min

Study: Lessons learned from 20 years of snakebites

The best way to avoid getting bitten by a venomous snake is to not go looking for one in the first place. Like eating well and exercising to feel better, the avoidance approach is fully backed by science. A new study from University of Florida Health researchers analyzed 20 years of snakebites cases seen at UF Health Shands Hospital in Gainesville. “This is the first time we’ve evaluated two decades of venomous snakebites here,” said senior author and assistant professor of medicine Norman L. Beatty, M.D., FACP. Researchers analyzed 546 de-identified patient records from 2002 to 2022 and highlighted notable conclusions — for instance, that a third of the snakebites analyzed were preventable and caused by people intentionally engaging with wild snakes. “Typically, people’s experiences with getting bitten are due to an interaction that was inadvertent — they stumble upon a snake or reach for something without seeing one camouflaged,” Beatty said. “In this case, people were seeking them out. There were a few individuals who were bitten on more than one occasion.” Most (77.8%) of the snakebites occurred in adult men while they were handling wild snakes, and most of the bites were perpetrated by the diminutive pygmy rattlesnake and the cottonmouth. The latter is named for the white lining of its mouth, which it displays when threatened. “I was less surprised to see those species emerge as some of the most common ones people were bitten by, but the robust presence of other, less common species in the data — like the eastern coral snake, southern copperhead, timber rattlesnake and the eastern diamondback rattlesnake, was interesting,” Beatty said. The eastern diamondback rattlesnake is one of the most venomous snakes in North America. Most patients were bitten on their hands and fingers and around 10% of them attempted outdated self-treatments no longer recommended by doctors — like sucking out the venom. Initially, the study began as a medical student research project, thanks to a handful of medical students who worked with Beatty to review the cases. The intention was to dive deep into the circumstances of each encounter and learn more about the treatment given, as well as the outcomes. Fourth-year medical student River Grace, the paper’s first author, said the work struck a personal note. “My dad is a reptile biologist, so I’ve grown up around snakes my whole life,” Grace said. “He was bitten by a venomous snake many years ago and ended up hospitalized for multiple weeks, so it was interesting to keep that experience in mind while going over the data.” Grace noted that it typically took those bitten over an hour on average to travel from where the bite occurred to the hospital. “It seems like the reason for that was people not knowing exactly what to do once they’d been bitten, or underestimating the severity of the bite,” he said. “Some would just sit at home for hours.” Floridians share their home with a variety of scaly neighbors who don’t always welcome visitors — accidental or not. Ultimately, thanks to the timely care of providers, only three snake bites were fatal. However, antivenom is no panacea. Those who are lucky enough to receive it in time can still incur complications from the original snake bites, like tissue damage, or even a fatal allergic reaction to the antivenom itself. Consequently, researchers look toward improving the processes used to triage snake bites in the emergency room, ensuring that providers are equipped with the knowledge and the know-how to shorten time to treatment. “In the future, we think we’d love to get involved in enhancing provider education so everyone in the health care setting is confident in being able to identify and administer antivenom as quickly and safely as possible,” Grace said.

4 min

UF team develops AI tool to make genetic research more comprehensive

University of Florida researchers are addressing a critical gap in medical genetic research — ensuring it better represents and benefits people of all backgrounds. Their work, led by Kiley Graim, Ph.D., an assistant professor in the Department of Computer & Information Science & Engineering, focuses on improving human health by addressing "ancestral bias" in genetic data, a problem that arises when most research is based on data from a single ancestral group. This bias limits advancements in precision medicine, Graim said, and leaves large portions of the global population underserved when it comes to disease treatment and prevention. To solve this, the team developed PhyloFrame, a machine-learning tool that uses artificial intelligence to account for ancestral diversity in genetic data. With funding support from the National Institutes of Health, the goal is to improve how diseases are predicted, diagnosed, and treated for everyone, regardless of their ancestry. A paper describing the PhyloFrame method and how it showed marked improvements in precision medicine outcomes was published Monday in Nature Communications. Graim, a member of the UF Health Cancer Center, said her inspiration to focus on ancestral bias in genomic data evolved from a conversation with a doctor who was frustrated by a study's limited relevance to his diverse patient population. This encounter led her to explore how AI could help bridge the gap in genetic research. “If our training data doesn’t match our real-world data, we have ways to deal with that using machine learning. They’re not perfect, but they can do a lot to address the issue.” —Kiley Graim, Ph.D., an assistant professor in the Department of Computer & Information Science & Engineering and a member of the UF Health Cancer Center “I thought to myself, ‘I can fix that problem,’” said Graim, whose research centers around machine learning and precision medicine and who is trained in population genomics. “If our training data doesn’t match our real-world data, we have ways to deal with that using machine learning. They’re not perfect, but they can do a lot to address the issue.” By leveraging data from population genomics database gnomAD, PhyloFrame integrates massive databases of healthy human genomes with the smaller datasets specific to diseases used to train precision medicine models. The models it creates are better equipped to handle diverse genetic backgrounds. For example, it can predict the differences between subtypes of diseases like breast cancer and suggest the best treatment for each patient, regardless of patient ancestry. Processing such massive amounts of data is no small feat. The team uses UF’s HiPerGator, one of the most powerful supercomputers in the country, to analyze genomic information from millions of people. For each person, that means processing 3 billion base pairs of DNA. “I didn’t think it would work as well as it did,” said Graim, noting that her doctoral student, Leslie Smith, contributed significantly to the study. “What started as a small project using a simple model to demonstrate the impact of incorporating population genomics data has evolved into securing funds to develop more sophisticated models and to refine how populations are defined.” What sets PhyloFrame apart is its ability to ensure predictions remain accurate across populations by considering genetic differences linked to ancestry. This is crucial because most current models are built using data that does not fully represent the world’s population. Much of the existing data comes from research hospitals and patients who trust the health care system. This means populations in small towns or those who distrust medical systems are often left out, making it harder to develop treatments that work well for everyone. She also estimated 97% of the sequenced samples are from people of European ancestry, due, largely, to national and state level funding and priorities, but also due to socioeconomic factors that snowball at different levels – insurance impacts whether people get treated, for example, which impacts how likely they are to be sequenced. “Some other countries, notably China and Japan, have recently been trying to close this gap, and so there is more data from these countries than there had been previously but still nothing like the European data," she said. “Poorer populations are generally excluded entirely.” Thus, diversity in training data is essential, Graim said. "We want these models to work for any patient, not just the ones in our studies," she said. “Having diverse training data makes models better for Europeans, too. Having the population genomics data helps prevent models from overfitting, which means that they'll work better for everyone, including Europeans.” Graim believes tools like PhyloFrame will eventually be used in the clinical setting, replacing traditional models to develop treatment plans tailored to individuals based on their genetic makeup. The team’s next steps include refining PhyloFrame and expanding its applications to more diseases. “My dream is to help advance precision medicine through this kind of machine learning method, so people can get diagnosed early and are treated with what works specifically for them and with the fewest side effects,” she said. “Getting the right treatment to the right person at the right time is what we’re striving for.” Graim’s project received funding from the UF College of Medicine Office of Research’s AI2 Datathon grant award, which is designed to help researchers and clinicians harness AI tools to improve human health.

1 min

Opinion: Hey Florida! Want to go to Mars? Here’s what it will do to your body

The president is eager “to plant the stars and stripes on the planet Mars.” Would you sign up for that mission? What would happen to your body in the three years you would be gone? As the United States continues to prioritize space travel, you might wonder why anyone would want to travel to Mars and whether it’s even ethical to expose humans to such extreme physiological conditions. The world is watching as the astronauts on the Boeing Starliner remain stuck in space until at least March due to a capsule malfunction. So many questions have arisen about the impacts of people spending extended periods of time in space, and we don’t have all the answers yet. However, because I study how spaceflight affects human physiology and performance, I have some ideas. The first 10 minutes of your journey will be exciting, but it’s the next months and years we really need to worry about. We have solved some of the problems but not all. After you lift off, the high g-forces will paste your body against the crew couch as you accelerate, but there’s really not too much to fear. A typical launch results in only about half the acceleration experienced by a fighter pilot in a tight turn. You might feel lightheaded, but astronauts have dealt with this for generations. Read the full article in the Tampa Bay Times here:

View all posts